These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 28844116)

  • 21. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic.
    Velez NF; Wei-Passanese EX; Husni ME; Mody EA; Qureshi AA
    Arch Dermatol Res; 2012 Jan; 304(1):7-13. PubMed ID: 21904925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemic cardiovascular involvement in psoriasis: a systematic review.
    Mosca S; Gargiulo P; Balato N; Di Costanzo L; Parente A; Paolillo S; Ayala F; Trimarco B; Crea F; Perrone-Filardi P
    Int J Cardiol; 2015 Jan; 178():191-9. PubMed ID: 25464252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS).
    Dalal DS; Lin YC; Brennan DM; Borkar N; Korman N; Husni ME
    Semin Arthritis Rheum; 2015 Jun; 44(6):641-5. PubMed ID: 26058346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?
    Sunbul M; Agirbasli M
    Curr Pharm Des; 2014; 20(4):529-35. PubMed ID: 23565636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.
    Boehncke WH; Boehncke S
    Curr Rheumatol Rep; 2012 Aug; 14(4):343-8. PubMed ID: 22562431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoriasis as a cardiovascular risk factor: updates and algorithmic approach.
    Cozzani E; Rosa GM; Burlando M; Parodi A
    G Ital Dermatol Venereol; 2018 Oct; 153(5):659-665. PubMed ID: 29683293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of comorbidities in psoriasis.
    Naldi L; Mercuri SR
    Dermatol Ther; 2010; 23(2):114-8. PubMed ID: 20415817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
    Mehta H; Narang T; Dogra S; Handa S; Hatwal J; Batta A
    Vasc Health Risk Manag; 2024; 20():215-229. PubMed ID: 38745849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular risk in patients with psoriatic arthritis].
    Korotaeva TV; Novikova DS; Loginova EY
    Ter Arkh; 2016; 88(5):102-106. PubMed ID: 27458624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers.
    Mazzilli S; Lanna C; Chiaramonte C; Cesaroni GM; Zangrilli A; Palumbo V; Cosio T; Dattola A; Gaziano R; Galluzzo M; Chimenti MS; Gisondi P; Bianchi L; Campione E
    J Dermatol; 2020 Jun; 47(6):578-582. PubMed ID: 32239555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cardiometabolic conditions of psoriatic disease.
    Toussirot E; Gallais-Sérézal I; Aubin F
    Front Immunol; 2022; 13():970371. PubMed ID: 36159785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics.
    Carubbi F; Chimenti MS; Blasetti G; Cipriani P; Musto A; Fargnoli MC; Perricone R; Giacomelli R; Peris K
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2160-8. PubMed ID: 25882399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel anti-inflammatory therapies to reduce cardiovascular burden of psoriasis.
    Piros ÉA; Szilveszter B; Vattay B; Maurovich-Horvat P; Szalai K; Dósa E; Merkely B; Holló P
    Dermatol Ther; 2021 Jan; 34(1):e14721. PubMed ID: 33373079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comorbidities in Psoriatic Arthritis: A Narrative Review.
    Panagiotopoulos A; Fragoulis GE
    Clin Ther; 2023 Feb; 45(2):177-189. PubMed ID: 36737317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic.
    Woo YR; Park CJ; Kang H; Kim JE
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
    Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
    Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond skin deep: addressing comorbidities in psoriasis.
    Kovitwanichkanont T; Chong AH; Foley P
    Med J Aust; 2020 Jun; 212(11):528-534. PubMed ID: 32388913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review.
    Jamnitski A; Symmons D; Peters MJ; Sattar N; McInnes I; Nurmohamed MT
    Ann Rheum Dis; 2013 Feb; 72(2):211-6. PubMed ID: 22532629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.
    Peluso R; Caso F; Tasso M; Ambrosino P; Dario Di Minno MN; Lupoli R; Criscuolo L; Caso P; Ursini F; Puente AD; Scarpa R; Costa On Behalf Of CaRRDs Study Group L
    Rev Recent Clin Trials; 2018; 13(3):199-209. PubMed ID: 29542417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.